SAV1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
8.24895707296491E-14 |
Normal-vs-Stage2 |
4.58309999951112E-08 |
Normal-vs-Stage3 |
<1E-12 |
Normal-vs-Stage4 |
1.62447832963153E-12 |
Stage1-vs-Stage2 |
2.759800E-01 |
Stage1-vs-Stage3 |
9.20389999770066E-08 |
Stage1-vs-Stage4 |
1.38300004781655E-09 |
Stage2-vs-Stage3 |
7.602500E-02 |
Stage2-vs-Stage4 |
1.228380E-02 |
Stage3-vs-Stage4 |
1.547580E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
<1E-12 |
Normal-vs-AfricanAmerican |
1.04249942012302E-11 |
Normal-vs-Asian |
1.161570E-03 |
Caucasian-vs-AfricanAmerican |
8.601800E-01 |
Caucasian-vs-Asian |
6.707000E-01 |
AfricanAmerican-vs-Asian |
7.255400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62447832963153E-12 |
Normal-vs-Female |
1.62447832963153E-12 |
Male-vs-Female |
7.937800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.27489999563113E-08 |
Normal-vs-Age(41-60Yrs) |
1.62492241884138E-12 |
Normal-vs-Age(61-80Yrs) |
1.62436730732907E-12 |
Normal-vs-Age(81-100Yrs) |
3.38840067115598E-13 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.059800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.274600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.916200E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.824100E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.524600E-03 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.029010E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.789890E-02 |
Normal-vs-Grade 2 |
1.01862962509358E-12 |
Normal-vs-Grade 3 |
1.62436730732907E-12 |
Normal-vs-Grade 4 |
1.62447832963153E-12 |
Grade 1-vs-Grade 2 |
1.796780E-01 |
Grade 1-vs-Grade 3 |
2.438000E-03 |
Grade 1-vs-Grade 4 |
2.2708000000371E-06 |
Grade 2-vs-Grade 3 |
1.59319999999408E-05 |
Grade 2-vs-Grade 4 |
6.98929802922521E-11 |
Grade 3-vs-Grade 4 |
3.759000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.62680979798324E-12 |
Normal-vs-ccB subtype |
2.99760216648792E-15 |
ccA subtype-vs-ccB subtype |
1.463580E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.62447832963153E-12 |
Normal-vs-N1 |
1.65223390524716E-12 |
N0-vs-N1 |
1.031820E-04 |
|
|